Literature DB >> 18255040

CFTR in a lipid raft-TNFR1 complex modulates gap junctional intercellular communication and IL-8 secretion.

Tecla Dudez1, Florence Borot, Song Huang, Brenda R Kwak, Marc Bacchetta, Mario Ollero, Bruce A Stanton, Marc Chanson.   

Abstract

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) cause a chronic inflammatory response in the lung of patients with Cystic Fibrosis (CF). We have showed that TNF-alpha signaling through the Src family tyrosine kinases (SFKs) was defective as determined by an inability of TNF-alpha to regulate gap junctional communication (GJIC) in CF cells. Here, we sought to elucidate the mechanisms linking TNF-alpha signaling to the functions of CFTR at the molecular level. In a MDCKI epithelial cell model expressing wild-type (WtCFTR) or mutant CFTR lacking its PDZ-interacting motif (CFTR-DeltaTRL), TNF-alpha increased the amount of WtCFTR but not CFTR-DeltaTRL in detergent-resistant membrane microdomains (DRMs). This recruitment was modulated by SFK activity and associated with DRM localization of TNFR1 and c-Src. Activation of TNFR1 signaling also decreased GJIC and markedly stimulated IL-8 production in WtCFTR cells. In contrast, the absence of CFTR in DRMs was associated with abnormal TNFR1 signaling as revealed by no recruitment of TNFR1 and c-Src to lipid rafts in CFTR-DeltaTRL cells and loss of regulation of GJIC and IL-8 secretion. These results suggest that localization of CFTR in lipid rafts in association with c-Src and TNFR1 provides a responsive signaling complex to regulate GJIC and cytokine signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18255040      PMCID: PMC5512004          DOI: 10.1016/j.bbamcr.2008.01.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

1.  CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa.

Authors:  H Grassmé; S Kirschnek; J Riethmueller; A Riehle; G von Kürthy; F Lang; M Weller; E Gulbins
Journal:  Science       Date:  2000-10-20       Impact factor: 47.728

2.  Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif.

Authors:  Kim Estell; Gavin Braunstein; Torry Tucker; Karoly Varga; James F Collawn; Lisa M Schwiebert
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 3.  Regulation of gap junctions by tyrosine protein kinases.

Authors:  Bonnie J Warn-Cramer; Alan F Lau
Journal:  Biochim Biophys Acta       Date:  2004-03-23

4.  CIN85 associates with TNF receptor 1 via Src and modulates TNF-alpha-induced apoptosis.

Authors:  Tadashi Narita; Tadahiro Nishimura; Kazuyuki Yoshizaki; Tadayoshi Taniyama
Journal:  Exp Cell Res       Date:  2004-12-01       Impact factor: 3.905

5.  Lipid rafts prepared by different methods contain different connexin channels, but gap junctions are not lipid rafts.

Authors:  Darren Locke; Jade Liu; Andrew L Harris
Journal:  Biochemistry       Date:  2005-10-04       Impact factor: 3.162

Review 6.  Plasma membrane microdomains.

Authors:  Frederick R Maxfield
Journal:  Curr Opin Cell Biol       Date:  2002-08       Impact factor: 8.382

7.  Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells.

Authors:  M Chanson; P Y Berclaz; I Scerri; T Dudez; K Wernke-Dollries; L Pizurki; A Pavirani; M A Fiedler; S Suter
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

8.  Connexin43 in MDCK cells: regulation by a tumor-promoting phorbol ester and Ca2+.

Authors:  V M Berthoud; M L Ledbetter; E L Hertzberg; J C Sáez
Journal:  Eur J Cell Biol       Date:  1992-02       Impact factor: 4.492

9.  Differential regulation of TNF-R1 signaling: lipid raft dependency of p42mapk/erk2 activation, but not NF-kappaB activation.

Authors:  Joyce E S Doan; David A Windmiller; David W H Riches
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

10.  Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.

Authors:  H Grassmé; V Jendrossek; A Riehle; G von Kürthy; J Berger; H Schwarz; M Weller; R Kolesnick; E Gulbins
Journal:  Nat Med       Date:  2003-02-03       Impact factor: 53.440

View more
  32 in total

1.  Membrane microdomains regulate NLRP10- and NLRP12-dependent signalling in A549 cells challenged with cigarette smoke extract.

Authors:  Dhirendra P Singh; Gagandeep Kaur; Prathyusha Bagam; Rakeysha Pinkston; Sanjay Batra
Journal:  Arch Toxicol       Date:  2018-04-06       Impact factor: 5.153

2.  Cholesterol modulates CFTR confinement in the plasma membrane of primary epithelial cells.

Authors:  Asmahan Abu-Arish; Elvis Pandzic; Julie Goepp; Elizabeth Matthes; John W Hanrahan; Paul W Wiseman
Journal:  Biophys J       Date:  2015-07-07       Impact factor: 4.033

Review 3.  Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors:  C N Belcher; N Vij
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

Review 4.  Cerebral artery myogenic reactivity: The next frontier in developing effective interventions for subarachnoid hemorrhage.

Authors:  Darcy Lidington; Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

5.  Cyclodextrins reduce the ability of Pseudomonas aeruginosa outer-membrane vesicles to reduce CFTR Cl- secretion.

Authors:  Roxanna Barnaby; Katja Koeppen; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

6.  Eicosanoid release is increased by membrane destabilization and CFTR inhibition in Calu-3 cells.

Authors:  Florence Borot; Diane-Lore Vieu; Grazyna Faure; Janine Fritsch; Julien Colas; Sandra Moriceau; Maryvonne Baudouin-Legros; Franck Brouillard; Jesus Ayala-Sanmartin; Lhousseine Touqui; Marc Chanson; Aleksander Edelman; Mario Ollero
Journal:  PLoS One       Date:  2009-10-22       Impact factor: 3.240

7.  Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling.

Authors:  Mairi J Hunter; Kate J Treharne; Alexandra K Winter; Diane M Cassidy; Stephen Land; Anil Mehta
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

8.  A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients.

Authors:  Ida Chiara Guerrera; Giuseppe Astarita; Jean-Philippe Jais; Dorota Sands; Anna Nowakowska; Julien Colas; Isabelle Sermet-Gaudelus; Martin Schuerenberg; Daniele Piomelli; Aleksander Edelman; Mario Ollero
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

9.  Long acting beta2-agonist and corticosteroid restore airway glandular cell function altered by bacterial supernatant.

Authors:  Jean-Marie Zahm; Franck Delavoie; Férial Toumi; Béatrice Nawrocki-Raby; Claire Kileztky; Jean Michel; Gérard Balossier; Malcolm Johnson; Christelle Coraux; Philippe Birembaut
Journal:  Respir Res       Date:  2010-01-20

10.  CFTR is a negative regulator of NFkappaB mediated innate immune response.

Authors:  Neeraj Vij; Steven Mazur; Pamela L Zeitlin
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.